| Literature DB >> 28734022 |
Marco Farina1,2, Andrea Ballerini1,3, Daniel W Fraga4, Eugenia Nicolov1, Matthew Hogan5, Danilo Demarchi2, Francesco Scaglione3, Omaima M Sabek4, Philip Horner5, Usha Thekkedath1, Osama A Gaber4, Alessandro Grattoni1.
Abstract
Transplantation of pancreatic islets or stem cell derived insulin secreting cells is an attractive treatment strategy for diabetes. However, islet transplantation is associated with several challenges including function-loss associated with dispersion and limited vascularization as well as the need for continuous immunosuppression. To overcome these limitations, here we present a novel 3D printed and functionalized encapsulation system for subcutaneous engraftment of islets or islet like cells. The devices were 3D printed with polylactic acid and the surfaces treated and patterned to increase the hydrophilicity, cell attachment, and proliferation. Surface treated encapsulation systems were implanted with growth factor enriched platelet gel, which helped to create a vascularized environment before loading human islets. The device protected the encapsulated islets from acute hypoxia and kept them functional. The adaptability of the encapsulation system was demonstrated by refilling some of the experimental groups transcutaneously with additional islets.Entities:
Keywords: 3D printing; diabetes; encapsulations; islets; transplantations
Mesh:
Substances:
Year: 2017 PMID: 28734022 DOI: 10.1002/biot.201700169
Source DB: PubMed Journal: Biotechnol J ISSN: 1860-6768 Impact factor: 4.677